Literature DB >> 16611680

Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.

Arduino Arduini, Mario Bonomini, Elaine J Clutterbuck, Michael A Laffan, Charles D Pusey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16611680     DOI： 10.1093/ndt/gfl155

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis.

Authors:  Yasuo Kudoh; Shinya Aoyama; Takaaki Torii; Qijie Chen; Daigo Nagahara; Hiromi Sakata; Akihiko Nozawa
Journal:  Cardiorenal Med       Date:  2014-03-21       Impact factor: 2.041

2.  L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.

Authors:  Lucile Mercadal; Mathieu Coudert; Anne Vassault; Laurence Pieroni; Alain Debure; Messaoud Ouziala; Hélène Depreneuf; Christine Fumeron; Aude Servais; Nader Bassilios; Jacques Bécart; Ubald Assogba; Mahmoud Allouache; Boussad Bouali; Nhan Luong; Marie Paul Dousseaux; Sophie Tezenas-du Montcel; Gilbert Deray
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-30       Impact factor: 8.237

3.  Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis.

Authors:  Yan Zhu; Chao Xue; Jihong Ou; Zhijuan Xie; Jin Deng
Journal:  Int Urol Nephrol       Date:  2021-03-13       Impact factor: 2.370

Review 4.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.